Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement

Amary, Fernanda; Perez-Casanova, Luis; Ye, Hongtao; Cottone, Lucia; Strobl, Anna-Christina; Cool, Paul; Miranda, Elena; Berisha, Fitim; Aston, William; Rocha, Maia; O'Donnell, Paul; Pillay, Nischalan; Tirabosco, Roberto; Baumhoer, Daniel; Hookway, Edward S.; Flanagan, Adrienne M.

Abstract

A fusion between fibronectin 1 (FN1) and activin receptor 2A (ACVR2A) has been reported previously in isolated cases of the synovial chondromatosis. To analyze further and validate the findings, we performed FISH and demonstrated recurrent FN1–ACVR2A rearrangements in synovial chondromatosis (57%), and chondrosarcoma secondary to synovial chondromatosis (75%), showing that FN1 and/or AVCR2A gene rearrangements do not distinguish between benign and malignant synovial chondromatosis. RNA sequencing revealed the presence of the FN1–ACVR2A fusion in several cases that were negative by FISH suggesting that the true prevalence of this fusion is potentially higher than 57%. In soft tissue chondromas, FN1 alterations were detected by FISH in 50% of cases but no ACVR2A alterations were identified. RNA sequencing identified a fusion involving FN1 and fibroblast growth factor receptor 2 (FGFR2) in the case of soft tissue chondroma and FISH confirmed recurrent involvement of both FGFR1 and FGFR2. These fusions were present in a subset of soft tissue chondromas characterized by grungy calcification, a feature reminiscent of phosphaturic mesenchymal tumor. However, unlike the latter, fibroblast growth factor 23 (FGF23) mRNA expression was not elevated in soft tissue chondromas harboring the FN1–FGFR1 fusion. The mutual exclusivity of ACVR2A rearrangements observed in synovial chondromatosis and FGFR1/2 in soft tissue chondromas suggests these represent separate entities. There have been no reports of malignant soft tissue chondromas, therefore differentiating these lesions will potentially alter clinical management by allowing soft tissue chondromas to be managed more conservatively.

Citation

Amary, F., Perez-Casanova, L., Ye, H., Cottone, L., Strobl, A., Cool, P., …Flanagan, A. M. (2019). Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement. Modern Pathology, 32(12), 1762-1771. https://doi.org/10.1038/s41379-019-0315-8

• Journal Article Type: Article
• Acceptance Date: Jun 4, 2019
• Online Publication Date: Jun 4, 2019
• Publication Date: 2019-12
• Deposit Date: Jun 13, 2023
• Journal: Modern Pathology
• Print ISSN: 0893-3952
• Electronic ISSN: 1530-0285
• Publisher: Nature Publishing Group
• Peer Reviewed: Peer Reviewed
• Volume: 32
• Issue: 12
• Pages: 1762-1771
• DOI: https://doi.org/10.1038/s41379-019-0315-8
• Keywords: Pathology and Forensic Medicine
• Publisher URL: https://www.sciencedirect.com/science/article/pii/S089339522200970X?via%3Dihub
• Additional Information: This article is maintained by: Elsevier; Article Title: Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement; Journal Title: Modern Pathology; CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41379-019-0315-8; Content Type: article; Copyright: © 2019 United States & Canadian Academy of Pathology.